Back to User profile » Dr Meiyuan Dong
Papers published by Dr Meiyuan Dong:
The Implication of Elevated Serum Myoglobin Level in Acute Diabetic Complications of Ketoacidosis and Hyperglycemic Hyperosmolar State: A Real-World Study
Xu C, Wen S, Gong M, Dong M, Yuan Y, Li Y, Zhou M, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2024, 17:2639-2653
Published Date: 1 July 2024
The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot
Li X, Wen S, Dong M, Yuan Y, Gong M, Wang C, Yuan X, Jin J, Zhou M, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3197-3211
Published Date: 17 October 2023
Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and Drugs
Huang X, Chen H, Wen S, Dong M, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1809-1819
Published Date: 21 June 2023
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy
Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1541-1554
Published Date: 30 May 2023
The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus
Dong M, Chen H, Wen S, Yuan Y, Yang L, Xu D, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:437-445
Published Date: 14 February 2023
The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance
Dong M, Chen H, Wen S, Yuan Y, Yang L, Li Y, Yuan X, Xu D, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2023, 16:425-435
Published Date: 14 February 2023
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
Dong M, Wen S, Zhou L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:2583-2597
Published Date: 22 August 2022